This inventor holds 1 USPTO granted patent and 11 published patent applications, plus 1 CIPO patent and 10 EPO patents. Top assignee: Belgian Volition Srl. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mark Edward Eccleston: Innovator in Immunology
Introduction
Mark Edward Eccleston is an inventor based in Isnes, Belgium. He has made significant contributions to the field of immunology, particularly in the development of innovative treatments and diagnostic methods. Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical science.
Latest Patent Applications
Mark Edward Eccleston has submitted several patent applications that reflect his innovative approach to healthcare. One of his latest applications is titled "Chimeric Antigen Receptor T-Cell Treatments Targeted to Chromatin Fragments and Extracellular Traps." This invention relates to engineered immune cells that comprise a chimeric antigen receptor or a T cell receptor, which is capable of specific binding to epitopes associated with neutrophil extracellular traps. Another significant application is for a "Diagnostic Method for Multiple Sclerosis," which involves methods for diagnosing patients with multiple sclerosis by detecting cell-free nucleosomes as biomarkers in body fluid samples.
Conclusion
Mark Edward Eccleston's work in immunology showcases his dedication to advancing medical science through innovative solutions. His latest patent applications highlight his commitment to addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile